News about Global Pharma

TechInvention Lifecare Bags Start-up 50: The Trailblazers Award

TechInvention Lifecare Pvt. Ltd. has secured the coveted 'Start-up 50: The Trailblazers Award' at the 2nd edition of the "Dun & Bradstreet LEAP India Startup Summit 2024," held at the Taj Bangalore.

Global Pharma | 19/06/2024 | By Aishwarya |  497

YolTech and KACTUS to Accelerate DNA Editing System in Greater China

YolTech has teamed up with KACTUS to advance the commercialization of YolTech's proprietary DNA editor, YolCas12, in Greater China.

Global Pharma | 19/06/2024 | By Aishwarya |  549

Haemonetics Releases Limited Market Release for New VASCADE MVP XL Vascular Closure Device

Haemonetics Corp. has rolled out a limited market release of its new VASCADE MVP XL mid-bore venous closure device.

Global Pharma | 19/06/2024 | By Aishwarya |  1005

Ascidian Partners with Roche for Development of RNA Exon Editing Therapeutics

Ascidian Therapeutics has signed a research collaboration and licensing agreement with Roche for the discovery and development of RNA exon editing therapeutics targeting neurological diseases.

Global Pharma | 19/06/2024 | By Aishwarya |  511

Thermo Fisher Scientific Unveils New Clinical Research Laboratory in Wisconsin

Thermo Fisher Scientific’s PPD clinical research business has launched a new clinical research laboratory building at its good manufacturing practices (GMP) lab in Middleton, Wisconsin.

Global Pharma | 19/06/2024 | By Aishwarya |  750

Spyre Announces First Participants Dosed in Phase 1 Trial of SPY001

Spyre Therapeutics, Inc. announced that it has initiated dosing of healthy volunteers in its first clinical trial of SPY001, an investigational novel half-life extended anti-α4β7 monoclonal antibody.

Global Pharma | 18/06/2024 | By Manvi |  373

Alembic Pharmaceuticals Gets Approval from USFDA for its Injection to Treat Rare Genetic Condition

The US Food & Drug Administration (USFDA) has granted Alembic Pharmaceuticals Limited final clearance for its Abbreviated New Drug Application (ANDA) for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe.

Global Pharma | 18/06/2024 | By Manvi |  247

Lupin Names Abdelaziz Toumi as CEO of its Subsidiary

Lupin has appointed Abdelaziz Toumi (Abdel) as the Chief Executive Officer of its newly formed subsidiary, Lupin Manufacturing Solutions (LMS).

Global Pharma | 18/06/2024 | By Aishwarya |  713

Syntegon Showcases New Settle Plate Changer at ACHEMA 2024

Syntegon has showcased an important new development at ACHEMA 2024 that generated a great deal of interest among pharmaceutical manufacturers: the patented Settle Plate Changer (SPC) for automated viable monitoring in the aseptic filling process.

Global Pharma | 18/06/2024 | By Aishwarya |  756

Takeda Signs Option Deal with Ascentage Pharma to Get Exclusive Global License for Olverembatinib

Takeda has signed an option agreement with Ascentage Pharma to enter into an exclusive license agreement for olverembatinib, an oral, potentially best-in-class, third-generation BCR-ABL tyrosine kinase inhibitor.

Global Pharma | 15/06/2024 | By Aishwarya |  750